Vitamin D and Tuberculosis

This publication has 18 references indexed in Scilit:

• Type 1 Helper T Cells and FoxP3-positive T Cells in HIV–Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome
  American Journal of Respiratory and Critical Care Medicine, 2008
• Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
  Clinical Infectious Diseases, 2008
• Antimicrobial Lock Solutions for the Prevention of Infections Associated with Intravascular Catheters in Patients Undergoing Hemodialysis: Systematic Review and Meta‐analysis of Randomized, Controlled Trials
  Clinical Infectious Diseases, 2008
• Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy
  American Journal of Respiratory and Critical Care Medicine, 2008
• Activation of the human immunodeficiency virus type I long terminal repeat by 1α,25-dihydroxyvitamin D3
  Journal of Molecular Endocrinology, 2007
• Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
  Science, 2006
• Characterization and Management of Paradoxical Upgrading Reactions in HIV-Uninfected Patients with Lymph Node Tuberculosis
  Clinical Infectious Diseases, 2005
• Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults
  New England Journal of Medicine, 2004
• A Randomized, Double‐Blind, Placebo‐Controlled Trial of the Use of Prednisolone as an Adjunct to Treatment in HIV‐1–Associated Pleural Tuberculosis
  The Journal of Infectious Diseases, 2004
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001